Chief Financial Officer @ (January 2021 - July 2022)
Vice President, Finance and Interim Principle Financial Officer @ Akcea Therapeutics (acquired by Ionis Pharmaceuticals in 2020) (January 2019 - January 2020)
Vice President, Head of Financial Planning and Analysis @ Moderna Therapeutics (January 2016 - January 2019)
Senior Director, Finance @ (January 2013 - January 2016)
Vice President, Finance and Treasury @ (January 2012 - January 2013)
Executive Director, Financial Planning and Analysis @ (January 2010 - January 2012)
Senior Director, Financial Planning and Analysis @ (January 2008 - January 2010)
Director, Financial Planning and Analysis @ (January 2007 - January 2008)
Director of Finance @ (January 2005 - January 2007)
Senior Manager, Operations Finance @ (January 2003 - January 2005)
Manager, Corporate Business Analysis @ (January 2000 - January 2003)
Rob Dolski Education
The Wharton School
MBA (Finance)
University of Pennsylvania
BS (Civil Engineering and Economics)
Rob Dolski Skills
Accounting
Acquisition Integration
Analysis
Biopharmaceuticals
Budgeting
Budgets
Business Development
Business Planning
Cash Flow Forecasting
Commercialization
Competitive Analysis
Corporate Development
Corporate Finance
Cost Accounting
Due Diligence
Executive Management
Finance
Financial Analysis
Financial Modeling
Financial Planning
Financial Reporting
Forecasting
Global Alliance Management
Investor Relations
Leadership
Life Sciences
Lifesciences
M&A experience
Management
Managerial Finance
Pharmaceutical Industry
Portfolio Management
Product Management
Sarbanes-Oxley Act
Start-ups
Strategic Financial Planning
Strategic Partnerships
Strategy
Treasury Management
Valuation
Venture Capital
Biotechnology
Mergers & Acquisitions
Cross-functional Team Leadership
Business Analysis
Cross Functional Team Leadership
Start Ups
Project Management
Strategic Planning
Mergers and Acquisitions
Sarbanes Oxley Act
Rob Dolski Summary
Rob Dolski, based in Boston, MA, US, is currently a Chief Financial Officer at Autolus Ltd.. Rob Dolski brings experience from previous roles at Odyssey Therapeutics, Checkmate Pharmaceuticals, Akcea Therapeutics (acquired by Ionis Pharmaceuticals in 2020) and Moderna Therapeutics. Rob Dolski holds a MBA in Finance @ The Wharton School. With a robust skill set that includes Accounting, Acquisition Integration, Analysis, Biopharmaceuticals, Budgeting and more. Rob Dolski has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Rob Dolski?
Find contact details for 700 million professionals.